In summary, the mRNA levels of EGFR and ERBB2 were higher in advanced and poorly differentiated gliomas; however, the mRNA levels of ERBB3 and ERBB4 were lower in advanced and poorly differentiated gliomas. Here, ERBB4 is linked to central nervous system cancer.